Oncolytic Virus Therapy Market Trends, Revenue, Major Players, Share Analysis & Forecast by 2027 The report offers insightful information about the market dynamics of the Oncolytic Virus Therapy market. It offers SWOT analysis, PESTEL analysis, and Porter’s Five Forces analysis to present a better understanding of the Oncolytic Virus Therapy market, competitive landscape, factors affecting it, and to predict the growth of the industry. It also offers the impact of various market factors along with the effects of the regulatory framework on the growth of the Oncolytic Virus Therapy market. The global oncolytic virus therapy market size is expected to reach USD 866.1 Million at a steady CAGR of 23.9% in 2028, according to latest analysis by Emergen Research. Steady growth of oncolytic virus therapy market can be attributed to rising cancer incidence globally. Cancer is a major cause of deaths in countries across the globe and it is estimated that in 2020, over 1.8 million new cancer cases were diagnosed in the US, with over 0.6 Million deaths occurring due to the disease. Also, around 70% of cancer mortality occurs in low and middle-income countries. Oncolytic virus therapy (a type of immunotherapy) uses engineered viruses to destroy cancer cells without affecting healthy cells in the human body. Once a cancer cell is destroyed, it releases cancer antigens that trigger immune responses to destroy other tumor cells in the body. Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/541